Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy, a Double-blind, Randomized Controlled Study

NCT01547520 is registered in ClinicalTrials.gov with Dalin Tzu Chi General Hospital as lead sponsor.

NCT NCT01547520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01547520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Meperidine as the Single Sedative Agent During Esophagogastroduodenoscopy, a Double-blind, Randomized Controlled Study
Lead sponsor
Dalin Tzu Chi General Hospital
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
February 29, 2012
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophagogastroduodenoscopy